ID   HeLa S3 AGO2KO
AC   CVCL_A0DW
SY   HeLaS3 AGO2KO
DR   GEO; GSM4224316
DR   Wikidata; Q108820454
RX   PubMed=30591524;
RX   PubMed=33205894;
CC   Population: African American.
CC   Knockout cell: Method=ZFN; HGNC; 3263; AGO2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: scRNAseq analysis.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 5
//
RX   PubMed=30591524; DOI=10.15252/embr.201845969;
RA   Laudadio I., Orso F., Azzalin G., Calabro C., Berardinelli F.,
RA   Coluzzi E., Gioiosa S., Taverna D., Sgura A., Carissimi C., Fulci V.;
RT   "AGO2 promotes telomerase activity and interaction between the
RT   telomerase components TERT and TERC.";
RL   EMBO Rep. 20:e45969.1-e45969.12(2019).
//
RX   PubMed=33205894; DOI=10.15252/msb.20209946;
RA   Schwabe D., Formichetti S., Junker J.P., Falcke M., Rajewsky N.;
RT   "The transcriptome dynamics of single cells during the cell cycle.";
RL   Mol. Syst. Biol. 16:e9946.1-e9946.20(2020).
//